<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37922371</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-3062</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Transplant infectious disease : an official journal of the Transplantation Society</Title><ISOAbbreviation>Transpl Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Post-acute sequelae of COVID-19 in solid organ transplant recipients.</ArticleTitle><Pagination><StartPage>e14167</StartPage><MedlinePgn>e14167</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/tid.14167</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC), defined as prolonged symptoms following an episode of COVID-19, is not well-characterized in solid organ transplant recipients (SOTR). In this study, we aimed to assess the prevalence of PASC in SOTR, its descriptive characteristics, and associated risk factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively identified SOTRs with acute COVID-19 between June 1, 2020 and April 15, 2022, and abstracted demographic and medical history, characteristics of acute COVID-19 illness, and COVID-19 vaccination status. We defined PASC as ongoing/new symptoms present at 6&#xa0;weeks or longer following acute COVID-19 diagnosis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 208 SOTRs with acute COVID-19, 72 (35%) developed PASC. Common symptoms were respiratory symptoms (67%), headache (40%), and difficulty concentrating (10%). Severe acute COVID-19 disease and presence of respiratory symptoms were associated with higher odds of PASC in multivariable analyses, while receipt of at least one COVID-19 vaccination prior to transplantation was protective.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We found that PASC occurs in about a third of SOTRs with acute COVID-19 and has similar symptoms as described previously in immunocompetent hosts. Pre-transplant vaccination may be protective. Further prospective multicenter studies are needed.</AbstractText><CopyrightInformation>&#xa9; 2023 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sigler</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8861-1150</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, The University of Kansas Health System, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covarrubias</LastName><ForeName>Karina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California, San Diego, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease and Global Public Health, Department of Medicine, University of California, San Diego, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubarth</LastName><ForeName>Rodrigo Barriola</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Diego, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torosian</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Diego, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Claudia Ramirez</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California, San Diego, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bharti</LastName><ForeName>Ajay</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California, San Diego, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeGruttola</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard University School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aslam</LastName><ForeName>Saima</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4051-5629</Identifier><AffiliationInfo><Affiliation>Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California, San Diego, San Diego, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T15 LM011271</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15LM011271</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Transpl Infect Dis</MedlineTA><NlmUniqueID>100883688</NlmUniqueID><ISSNLinking>1398-2273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016377" MajorTopicYN="Y">Organ Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066027" MajorTopicYN="Y">Transplant Recipients</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">immunocompromise</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19</Keyword><Keyword MajorTopicYN="N">solid organ transplant</Keyword></KeywordList><CoiStatement>Potential Conflicts of Interest: RS: declares no conflict of interest. KC: declares no conflict of interest. BC: declares no conflict of interest. CR: declares no conflict of interest. RR: declares no conflict of interest. KT: declares no conflict of interest. AB: declares no conflict of interest. VG: declares no conflict of interest. SA: Consultant for BioMx and Phico. Medical Advisory Board for Pherecydes. Research funding from the Cystic Fibrosis Foundation, NIH/NCATS, NIH/NIAID and Contrafect Corporation.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>14</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37922371</ArticleId><ArticleId IdType="mid">NIHMS1939159</ArticleId><ArticleId IdType="pmc">PMC10841400</ArticleId><ArticleId IdType="doi">10.1111/tid.14167</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prevention CfDCa. Long COVID or Post-COVID Conditions
Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.
Accessed
June 6th.</Citation></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine 2021; 36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E, Gavriatopoulou M, Hicklen RS, et al. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review. J Infect 2021; 83(1): 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D, Ballouz T, Anagnostopoulos A, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLOS ONE 2021; 16(7): e0254523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLOS Medicine 2021; 18(9): e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigler R, Aslam S. SARS-CoV-2 vaccine clinical efficacy in SOT: What we know and our current gaps. Transpl Infect Dis 2022: e13809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9019848</ArticleId><ArticleId IdType="pubmed">35148028</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA 2021; 325(21): 2204&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8100911</ArticleId><ArticleId IdType="pubmed">33950155</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam H, Roberts SC, Tanna SD, Ison MG. 540. Prolonged Viral Shedding of SARS-CoV-2 In Solid Organ Transplant Recipients. Open Forum Infectious Diseases 2020; 7(Supplement_1): S337&#x2013;S.</Citation></Reference><Reference><Citation>Bartelt L, van Duin D. An overview of COVID-19 in solid organ transplantation. Clinical Microbiology and Infection 2022; 28(6): 779&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8855607</ArticleId><ArticleId IdType="pubmed">35189336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SM, Liu TC, Motwani Y, et al. Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort. J Gen Intern Med 2022; 37(8): 1988&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>Benotmane I, Risch S, Doderer-Lang C, Caillard S, Fafi-Kremer S. Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19. Am J Transplant 2021; 21(8): 2871&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222938</ArticleId><ArticleId IdType="pubmed">33961334</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidelines NIoHC- T. Clinical Spectrum of SARS-CoV-2 Infection
Available at: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/. Accessed
May 1st.</Citation></Reference><Reference><Citation>Prevention CfDCa. COVID data tracker: monitoring variant proportions
Available at: https://covid.cdc.gov/covid-data-tracker/#variantproportions Accessed
May 2nd.</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine 2021; 38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol 2022; 94(1): 253&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nature Medicine 2021; 27(4): 601&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. The Lancet Regional Health &#x2013; Europe 2021; 6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrangelo A, Bonato M, Cinque P. Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes. Neurosci Lett 2021; 748: 135694-.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7883672</ArticleId><ArticleId IdType="pubmed">33600902</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta-Etessam J, N&#xfa;&#xf1;ez-Gil IJ, Gonz&#xe1;lez Garc&#xed;a N, et al. COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Infection 2021; 49(4): 677&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7917537</ArticleId><ArticleId IdType="pubmed">33646505</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorim CEN, Gomes VLT, Cristelli MP, et al. High Prevalence of Long-COVID Among Kidney Transplant Recipients: A Longitudinal Cohort Study. Transplantation 2022; 106(12): 2408&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9696768</ArticleId><ArticleId IdType="pubmed">36228200</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet 2021; 397(10270): 220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali VT NM, Chand R, Sureau k, Mehta S, Montgomery R. The Impact Of Monoclonal Antibody Against Sars-CoV2 And Vaccination On Outcomes In Kidney Transplant Recipients With Covid-19 American Transplant Congress. Boston MA, 2022.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>